Hemophilia Market Share

Market Share of Hemophilia Industry

The hemophilia market is moderately competitive and consists of a few major players. The key players are also involved in various strategic alliances such as acquisitions, collaborations, and launching advanced products and research studies to secure their position in the global market. Some of the key market players in this market include Bayer AG, BioMarin, CSL Limited (CSL Behring), Novo Nordisk, Pfizer, Inc., Sanofi (Genzyme Corporation), Takeda Pharmaceutical Company Limited (Shire Plc.), among others.

Hemophilia Market Leaders

1. Pfizer, Inc.

2. Bayer AG

3. Novo Nordisk A/S

4. CSL Limited (CSL Behring)

5. BioMarin

*Disclaimer: Major Players sorted in no particular order